ABMD News Abiomed 60.15 $ABMD Current Happenings in

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
ABMD News Abiomed 60.15 $ABMD

Current Happenings in Financial Services Sector: Special Research on Asta Funding, Athens Bancshares, Atlantic American, Atlantic Coast Financial, and Atlanticus Holdings
PR Newswire - Tue Feb 03, 8:00AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Asta Funding (NASDAQ: ASFI), Athens Bancshares (NASDAQ: AFCB), Atlantic American (NASDAQ: AAME), Atlantic Coast Financial (NASDAQ: ACFC), and Atlanticus Holdings (NASDAQ: ATLC). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
AFCB: 26.25 (+0.27), ATLC: 2.85 (+0.04), AAME: 4.03 (+0.01), ASFI: 8.40 (-0.02), ACFC: 3.95 (+0.01)

Atlantic American Appoints Joseph M. Scheerer to Board of Directors
GlobeNewswire - Wed Dec 10, 1:11PM CST
Atlantic American Corporation (Nasdaq:AAME) today announced that Joseph M. Scheerer had been elected to the Company's Board of Directors effective December 8, 2014. Mr. Scheerer is the Principal and Managing Director of Stonybrook Capital based in New York, NY, a merchant banking firm focused on the insurance industry. Holborn Corporation, one of the largest independent reinsurance brokers in the U.S., is an equity partner with Stonybrook.
AAME: 4.03 (+0.01)

A.M. Best Affirms Ratings of Atlantic American Corporation and Its Subsidiaries
Business Wire - Wed Nov 12, 2:22PM CST
A.M. Best has affirmed the financial strength rating (FSR) of A (Excellent) and the issuer credit ratings (ICR) of "a" of American Southern Insurance Company (Topeka, KS) and its wholly owned and 100% reinsured subsidiary, American Safety Insurance Company (collectively referred to as American Southern Group). Concurrently, A.M. Best has affirmed the ICR of "bbb-" of the parent company, Atlantic American Corporation (Atlantic American) (NASDAQ:AAME).
AAME: 4.03 (+0.01)

Atlantic American Reports Increased Year to Date Operating Income
GlobeNewswire - Mon Nov 10, 8:55AM CST
-- Insurance premiums and operating earnings increase 6.9% and 2.0%, respectively, during the nine month period ended September 30, 2014 as compared to the comparable period in 2013.
AAME: 4.03 (+0.01)

Atlantic American declares $0.02 dividend
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 8:38AM CDT

AAME: 4.03 (+0.01)

Special Cash Dividend Declared by Atlantic American
GlobeNewswire - Thu Oct 30, 8:23AM CDT
Atlantic American Corporation (Nasdaq:AAME) today announced that its board of directors has declared a special dividend of $0.02 per share that will be payable on or about December 5, 2014, to shareholders of record as of November 14, 2014. This special dividend is in addition to and does not impact any future regular dividends.
AAME: 4.03 (+0.01)

Atlantic American Reports Increased Operating Income
GlobeNewswire - Mon Aug 11, 9:00AM CDT
-- Operating income for the six month period ended June 30, 2014 increased to $1.4 million from $0.9 million for the comparable period of 2013
AAME: 4.03 (+0.01)

Le Meridien Tampa Debuts in Century-Old Courthouse in the Heart of Downtown
Business Wire - Mon Jun 23, 10:39AM CDT
Starwood Hotels & Resorts Worldwide, Inc. (NYSE:HOT) today announced the debut of Le Meridien Tampa, following an adaptive re-use project that has transformed a century-old federal courthouse into the city's newest hotel. Developed by Memphis-based Development Services Group and owned via joint venture between its CEO and President Gary Prosterman and the Atlantic American Opportunity Fund, Le Meridien Tampa offers 130 contemporary guestrooms, a modern restaurant and state-of-the-art meeting and event space all set against the backdrop of the building's stunning architecture and location in the heart of the city's downtown arts and entertainment district.
AAME: 4.03 (+0.01), HOT: 82.33 (-0.53)

Zacks Rank #5 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
CAJ: 32.47 (-0.08), AAOI: 13.02 (-0.25), ATI: 33.25 (-0.48), HIVE: 4.62 (-0.13), BIO: 133.15 (+0.68)

Nasdaq stocks posting largest percentage increases
AP - Thu Feb 26, 12:19PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
AAOI: 13.02 (-0.25), SPNS: 8.01 (unch), FLML: 15.90 (+0.18), PCYC: 216.76 (-4.53), AKRX: 49.33 (-4.38), PGTI: 10.95 (-0.08), BNFT: 34.75 (+0.33), CBRX: 7.20 (-0.03), PLNR: 6.21 (+0.18), ONFC: 19.70 (-0.25), CYBX: 70.36 (+0.21)

Applied Optoelectronics' (AAOI) CEO Thompson Lin on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 25, 9:16PM CST

AAOI: 13.02 (-0.25)

Applied Optoelectronics posts 4Q profit
Automated Insights - Wed Feb 25, 5:24PM CST
SUGAR LAND, Texas (AP) _ Applied Optoelectronics Inc. (AAOI) on Wednesday reported fourth-quarter net income of $702,000, after reporting a loss in the same period a year earlier.
AAOI: 13.02 (-0.25)

Applied Optoelectronics beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 3:19PM CST

AAOI: 13.02 (-0.25)

Applied Optoelectronics to Announce Fourth Quarter and Year 2014 Financial Results on February 25, 2015
GlobeNewswire - Mon Jan 26, 3:03PM CST
Applied Optoelectronics, Inc. (Nasdaq:AAOI), a leading provider of fiber-optic access network products for the cable broadband, internet data center, and fiber-to-the-home markets, today announced that it will release financial results for its fourth quarter and year ended December 31, 2014 after U.S. markets close on Wednesday, February 25, 2015.
AAOI: 13.02 (-0.25)

Applied Optoelectronics Reports Preliminary Fourth Quarter 2014 Revenue
GlobeNewswire - Tue Jan 13, 3:03PM CST
Applied Optoelectronics, Inc. (Nasdaq:AAOI), a leading provider of fiber-optic access network products for the cable broadband, internet data center, and fiber-to-the-home markets, today announced preliminary revenue for the fourth quarter ended December 31, 2014.
AAOI: 13.02 (-0.25)

Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
ARCX: 19.23 (+0.30), AAOI: 13.02 (-0.25), BEAV: 63.89 (+0.08), BBRG: 13.41 (+0.21), BCOR: 14.46 (-0.58)

Applied Optoelectronics Completes Taiwan Factory Move
GlobeNewswire - Tue Dec 02, 7:30AM CST
Applied Optoelectronics, Inc. (Nasdaq:AAOI), a leading provider of fiber-optic access network products for the cable broadband, internet data center, and fiber-to-the-home markets, today announced the completion of the move to a new, larger factory in New Taipei City, Taiwan.
AAOI: 13.02 (-0.25)

Applied Optoelectronics, Inc. Ranked Number 374 Among the Fastest Growing Companies in North America on Deloitte's 2014 Technology Fast 500(TM)
GlobeNewswire - Thu Nov 13, 10:58AM CST
Applied Optoelectronics, Inc. (Nasdaq:AAOI) today announced it ranked No. 374 on Deloitte's Technology Fast 500(TM), a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. The ranking was based on Applied Optoelectronics' 214% revenue growth from 2009 to 2013.
AAOI: 13.02 (-0.25)

Midday gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 11:45AM CST

FSM: 4.38 (+0.07), HEAR: 2.28 (-0.10), JRJC: 6.33 (+0.77), CVO: 2.18 (+0.01), AAOI: 13.02 (-0.25), UNIS: 3.79 (-0.09), HIIQ: 7.49 (+0.23), CYAN: 8.14 (+0.05), PTX: 10.85 (+0.08), TRMR: 2.49 (+0.02), PRKR: 0.97 (-0.01), SUMR: 2.85 (+0.10), VSLR: 8.14 (+0.01), RVP: 4.07 (-0.05), ASCMA: 42.98 (-0.92), ICUI: 88.00 (-1.12), CALL: 8.03 (-0.25), DMD: 4.98 (-0.13), AST: 4.59 (+0.25), ASEI: 50.62 (-1.58)

Applied Optoelectronics (AAOI) Stock Lower After Earnings Miss
at The Street - Tue Nov 11, 9:55AM CST
Applied Optoelectronics (AAOI) is falling Tuesday after missing analysts' estimates for earnings in the third quarter
AAOI: 13.02 (-0.25)

Applied Optoelectronics misses by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:37PM CST

AAOI: 13.02 (-0.25)

Applied Optoelectronics Reports Sixth Consecutive Quarter of Record Revenue
GlobeNewswire - Mon Nov 10, 3:10PM CST
Third Quarter 2014 Highlights
AAOI: 13.02 (-0.25)

Infinera Stock Pops After Q3 Beat, Raised Outlook
at Investor's Business Daily - Thu Oct 23, 11:25AM CDT
Infinera stock soared to a more than six-year high Thursday after the fiber-optics parts maker posted Q3 earnings late Wednesday that blew past estimates and raised its Q4 guidance. Sunnyvale, Calif.-based Infinera (INFN) saw its stock rise 25% in...
FNSR: 20.55 (-0.78), AAOI: 13.02 (-0.25), JDSU: 13.51 (-0.30), CIEN: 20.75 (-0.23), INFN: 17.10 (-0.33)

iRobot Beats on Q3 Earnings, Hikes 2014 EPS Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 1:30PM CDT
iRobot Corporation (IRBT) reported strong earnings and improved year over year revenues for the third quarter of 2014.
AAOI: 13.02 (-0.25), AA: 15.18 (+0.23), IRBT: 33.65 (+0.18), AAPL: 129.36 (+0.27)

The Zacks Analyst Blog Highlights:iRobot, Alcoa, Applied Optoelectronics and Apple
PR Newswire - Wed Oct 22, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the iRobot Corporation (Nasdaq:IRBT-Free Report), Alcoa Inc. (NYSE:AA-Free Report), Applied Optoelectronics, Inc. (Nasdaq:AAOI-Free Report) and Apple Inc. (Nasdaq:AAPL-Free Report).
AAOI: 13.02 (-0.25), AA: 15.18 (+0.23)

iRobot to Ride Growth Trajectory on New Contracts - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 4:52PM CDT
Premier robot manufacturing company iRobot Corporation (IRBT) announced the receipt of a new contract from the Naval Surface Warfare Center, Indian Head Explosive Ordnance Disposal Technology Division.
AAOI: 13.02 (-0.25), AA: 15.18 (+0.23), IRBT: 33.65 (+0.18), AAPL: 129.36 (+0.27)

These 5 Big Caps Hit New Closing Highs
at Investor's Business Daily - Wed Feb 25, 7:02AM CST
A handful of big companies made big moves Tuesday as several Apple (AAPL) chip suppliers and two pharmaceutical distributors hit new closing highs. Today's Screen of the Day features Big Cap Leaders, generally top stocks with market values of at...
ABC: 103.04 (-0.06), MCK: 227.69 (-0.53), SWKS: 88.74 (-2.39), CAH: 88.43 (-1.09), TSM: 24.50 (-0.13), AAPL: 129.36 (+0.27), AVGO: 128.22 (-0.80)

Express Scripts (ESRX) Beats on Q4 Earnings & Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 8:30AM CST
Pharmacy benefit manager Express Scripts Holding Company posted fourth-quarter 2014 earnings per share (excluding special items) of $1.39, beating the Zacks Consensus Estimate by a penny.
ABC: 103.04 (-0.06), ESRX: 84.35 (-0.58), MCK: 227.69 (-0.53), CAH: 88.43 (-1.09)

AmerisourceBergen completes takeover of MWI Vet Supply
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 7:33AM CST

ABC: 103.04 (-0.06), MWIV: 190.00 (+0.10)

CR Bard's Lutonix DCB Gets Pass-Through Payment Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 5:14PM CST
Following a unanimous favorable recommendation from the FDA's Circulatory Systems Devices Advisory Panel, the CMS has approved a pass-through payment for CR Bard Inc.'s (BCR) Lutonix DCB.
HYH: 46.32 (-0.43), BSX: 16.76 (-0.30), ABC: 103.04 (-0.06), BCR: 167.18 (-1.12)

LabCorp Hits New 52-Week High on Strong Q4, Covance Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 8:42AM CST
On Feb 19, 2015, LabCorp (LH) finally completed the gigantic $5.7 billion acquisition of drug development major Covance Inc.
ABC: 103.04 (-0.06), MCK: 227.69 (-0.53), CAH: 88.43 (-1.09), LH: 123.86 (+0.50)

LabCorp Beats Q4 Earnings, Positive on Covance Addition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 20, 9:27AM CST
Laboratory Corporation of America Holdings (LH) reported a solid fourth-quarter 2014 with adjusted earnings per share (EPS) of $1.65, up 2.5% from the year-ago quarter.
ABC: 103.04 (-0.06), MCK: 227.69 (-0.53), CAH: 88.43 (-1.09), LH: 123.86 (+0.50)

AmerisourceBergen Up 51.2% Since SmarTrend Uptrend Call (ABC)
Comtex SmarTrend(R) - Thu Feb 19, 9:35AM CST
SmarTrend identified an Uptrend for AmerisourceBergen (NYSE:ABC) on May 12th, 2014 at $66.30. In approximately 9 months, AmerisourceBergen has returned 51.21% as of today's recent price of $100.25.
ABC: 103.04 (-0.06)

AmerisourceBergen prices USD1,000m senior notes
M2 - Wed Feb 18, 6:09AM CST
Pharmaceutical company AmerisourceBergen (NYSE:ABC) said on Tuesday that it has priced USD500m aggregate principal amount of its 3.25% Senior Notes due 1 March 2025 and USD500m aggregate principal amount of its 4.25% Senior Notes due 1 March 2045 (collectively, the "Notes" , in an underwritten registered public offering.
ABC: 103.04 (-0.06), MWIV: 190.00 (+0.10)

Vascular Solutions Set to Join the S&P SmallCap 600
PR Newswire - Tue Feb 17, 4:55PM CST
Vascular Solutions Inc. (NASD: VASC) will replace MWI Veterinary Supply Inc. (NASD: MWIV) in the S&P SmallCap 600 after the close of trading on Monday, February 23. S&P 500 constituent AmerisourceBergen Corp. (NYSE: ABC) is acquiring MWI Veterinary Supply in a transaction expected to be completed soon.
ABC: 103.04 (-0.06), MWIV: 190.00 (+0.10), VASC: 29.19 (-0.31), MHFI: 103.62 (+0.13)

AmerisourceBergen prices $1B debt offering
Seeking Alpha - at Seeking Alpha - Tue Feb 17, 2:47PM CST

ABC: 103.04 (-0.06)

AmerisourceBergen Prices $500 Million 3.25% Senior Notes Due 2025 and $500 Million 4.25% Senior Notes Due 2045
Business Wire - Tue Feb 17, 2:37PM CST
AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $500 million aggregate principal amount of its 3.25% Senior Notes due March 1, 2025 and $500 million aggregate principal amount of its 4.25% Senior Notes due March 1, 2045 (collectively, the "Notes" , in an underwritten registered public offering. The offering is being made pursuant to an effective shelf registration statement AmerisourceBergen filed with the Securities and Exchange Commission (the "SEC" on November 27, 2012. The offering is expected to close on February 20, 2015, subject to customary closing conditions. AmerisourceBergen intends to use the net proceeds from the offering, together with the net proceeds from the recently announced $1 billion senior unsecured term loan credit facility and cash on hand, to finance the previously disclosed proposed acquisition (the "Acquisition" of MWI Veterinary Supply, Inc. ("MWI" , and to pay related fees and expenses, including the retirement of all outstanding indebtedness of MWI. The offering is not contingent on the consummation of the Acquisition which, if completed, will occur subsequent to the closing of the offering. In the event that the Acquisition is not completed on or before May 15, 2015, or, if prior to such time, the acquisition agreement is terminated, other than in connection with the consummation of the Acquisition, and is not otherwise amended or replaced, then the Notes are subject to mandatory redemption, in whole but not in part, at a redemption price equal to 101% of the aggregate principal amount of the Notes, plus accrued and unpaid interest to, but not including, the redemption date. The Notes offering is expected to close prior to the consummation of the Acquisition.
ABC: 103.04 (-0.06), WFC: 55.45 (-0.10)

Fitch Affirms AmerisourceBergen's Ratings at 'A-'; Outlook Negative
Business Wire - Tue Feb 17, 1:24PM CST
Fitch Ratings has affirmed the ratings for AmerisourceBergen Corp. (NYSE: ABC), including the Long-term Issuer Default Rating (IDR) at 'A-'. The ratings have been removed form Negative Watch. The Rating Outlook is Negative.
ABC: 103.04 (-0.06)

MWI Veterinary: Benefits of Takeover by AmerisourceBergen - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 3:58PM CST
On Feb 11, 2015, we issued an updated research report on MWI Veterinary Supply Inc. (MWIV).
ABC: 103.04 (-0.06), MWIV: 190.00 (+0.10), CAH: 88.43 (-1.09), LH: 123.86 (+0.50)

Uptrend Call Working As AmerisourceBergen Stock Rises 48.6% (ABC)
Comtex SmarTrend(R) - Thu Feb 12, 9:11AM CST
SmarTrend identified an Uptrend for AmerisourceBergen (NYSE:ABC) on May 12th, 2014 at $66.29. In approximately 9 months, AmerisourceBergen has returned 48.59% as of today's recent price of $98.51.
ABC: 103.04 (-0.06)

Henry Schein (HSIC) Beats Q4 Earnings, Revenues in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:48AM CST
We are impressed with Henry Schein's (HSIC) fourth-quarter 2014 financial results which modestly beat the Zacks Consensus Estimate for EPS, while being in line with the same for revenues.
HYH: 46.32 (-0.43), ABC: 103.04 (-0.06), BRLI: 35.20 (-0.10), HSIC: 140.77 (-1.11)

AmerisourceBergen's World Courier Expands Global Presence with New Distribution Facility in Melbourne, Australia
PR Newswire - Wed Feb 11, 1:00PM CST
World Courier, the global leader in specialty logistics and an AmerisourceBergen company, has opened the doors to its new distribution facility in Melbourne, Australia. This is the first facility in AmerisourceBergen's global network to be purpose-built to support clinical trial logistics and commercial third-party logistics (3PL). In conjunction with World Courier's specialty logistics and transportation offerings, the facility provides a complete portfolio of supply chain solutions for pharmaceutical manufacturer partners.
ABC: 103.04 (-0.06)

Charles River (CRL) Beats on Q4 Earnings and Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 8:54AM CST
Charles River Laboratories (CRL) reported fourth-quarter 2014 earnings (excluding special items) of 81 cents per share, easily beating both the Zacks Consensus Estimate of 71 cents.
BIIB: 412.79 (-3.00), ABC: 103.04 (-0.06), MCK: 227.69 (-0.53), CRL: 75.62 (-1.13)

AmerisourceBergen Announces Expiration of the Hart-Scott-Rodino Waiting Period for AmerisourceBergen's Proposed Acquisition of MWI Veterinary Supply, Inc.
Business Wire - Wed Feb 11, 6:30AM CST
AmerisourceBergen Corporation (NYSE:ABC) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for its tender offer to purchase all outstanding shares of MWI Veterinary Supply, Inc. (NASDAQ: MWIV) has expired.
ABC: 103.04 (-0.06), MWIV: 190.00 (+0.10)

Health Care Providers and Services Equities Technical Momentum -- Cardinal Health, AmerisourceBergen, Community Health Systems, Select Medical Holdings, and McKesson
PR Newswire - Tue Feb 10, 7:35AM CST
Editor Note: For more information about this release, please scroll to bottom.
ABC: 103.04 (-0.06), MCK: 227.69 (-0.53), CAH: 88.43 (-1.09), CYH: 49.59 (+0.14), SEM: 13.68 (+0.05)

Why In The World Would AmerisourceBergen Acquire MWI Veterinary?
Rochelle Jenks - at Seeking Alpha - Tue Feb 10, 5:45AM CST

ABC: 103.04 (-0.06), MWIV: 190.00 (+0.10)

Symmetry Surgical Posts Loss in Q4, Revenues Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 10:50AM CST
Symmetry Surgical Inc. (SSRG) reported loss of $3.08 per share in the fourth quarter of 2014, which compares unfavorably with the year-ago quarter earnings of 4 cents.
ABMD: 60.15 (-2.04), FLDM: 41.78 (-2.39), SSRG: 7.46 (+0.02), LMNX: 15.64 (-0.45)

Insider Trading Alert - ABMD, WWWW And MSON Traded By Insiders
at The Street - Fri Feb 27, 10:45AM CST
Stocks with insider trader activity include ABMD, WWWW and MSON
ABMD: 60.15 (-2.04), WWWW: 17.57 (-0.24), MSON: 12.74 (+0.09)

Cyberonics Tops Q3 Earnings, VITARIA System Gets CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 9:00AM CST
Cyberonics (CYBX) reported a solid third-quarter fiscal 2015, registering a bottom-line beat and in-line revenues.
ABMD: 60.15 (-2.04), EW: 134.58 (-1.27), LMNX: 15.64 (-0.45), CYBX: 70.36 (+0.21)

Cyberonics Soars On Earnings Beat, Tax Inversion Deal
at Investor's Business Daily - Thu Feb 26, 12:58PM CST
Shares of Cyberonics (CYBX) gapped up to a record high Thursday after the company reported better than expected earnings growth and said it is merging with Italy's Sorin and moving its headquarters to Europe despite new Treasury rules intended to...
ABMD: 60.15 (-2.04), QSR: 43.62 (-1.05), MDT: 78.03 (-0.80), BAX: 69.42 (-0.54), SHPG: 238.90 (+2.48), EW: 134.58 (-1.27), ABBV: 59.62 (-0.84), CYBX: 70.36 (+0.21)

DexCom Reports Earnings in Q4, Top Line Surges Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 26, 8:54AM CST
DexCom Inc (DXCM) reported fourth-quarter 2014 EPS of 2 cents per share, which compares favorably with the Zacks Consensus Estimate of a loss of 3 cents and year-ago loss of 4 cents per share.
ABMD: 60.15 (-2.04), DXCM: 59.05 (-0.61), LMNX: 15.64 (-0.45), AAPL: 129.36 (+0.27)

Greatbatch Q4 Earnings Top on Solid Margins, Revenues Lag - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 25, 8:08AM CST
Greatbatch Inc. (GB) reported adjusted EPS of 65 cents in the fourth quarter of 2014, which beat the Zacks Consensus Estimate by 6 cents.
ABMD: 60.15 (-2.04), GB: 54.17 (-0.28), INGN: 33.34 (-0.28), LMNX: 15.64 (-0.45)

HeartWare Recalls Old Ventricular Assist System Controllers - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 6:00PM CST
HeartWare International, Inc. (HTWR) is issuing a voluntary Urgent Medical Device Recall for its older HeartWare Ventricular Assist System Controllers, in the U.S.
ABMD: 60.15 (-2.04), INGN: 33.34 (-0.28), LMNX: 15.64 (-0.45), HTWR: 84.70 (-0.41)

Adeptus Health Q4 Earnings Miss, Revenues in Line; Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 9:20AM CST
Operator of freestanding emergency rooms in the U.S., Adeptus Health Inc. (ADPT) announced fourth-quarter 2014 adjusted earnings per share (EPS) of 8 cents, which missed the Zacks Consensus Estimate by a couple of cents.
ABMD: 60.15 (-2.04), INGN: 33.34 (-0.28), LMNX: 15.64 (-0.45), ADPT: 43.80 (-1.48)

Teleflex Hits 52-Week High on Strong Q4, Strategic Deals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 7:16AM CST
Shares of Teleflex Inc (TFX) scaled a new 52-week high of $123.09 in mid-day trading on Feb 23.
ABMD: 60.15 (-2.04), FLDM: 41.78 (-2.39), TFX: 122.41 (-0.50), LMNX: 15.64 (-0.45)

Teleflex (TFX) Q4 Earnings, Revenues Top Estimates, Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 9:30AM CST
Teleflex Inc. (TFX) reported fourth-quarter 2014 adjusted earnings of $1.43 per share (EPS) which handily beat the Zacks Consensus Estimate of $1.39
ABMD: 60.15 (-2.04), INGN: 33.34 (-0.28), TFX: 122.41 (-0.50), LMNX: 15.64 (-0.45)

Accuray (ARAY) Catches Eye: Stock Adds 5.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 8:46AM CST
Accuray Incorporated (ARAY) was a big mover last session, as the company saw its shares rise over 5% on the day.
ABMD: 60.15 (-2.04), ARAY: 8.59 (-0.22)

Insider Trading Alert - ABMD, CCMP And SGMO Traded By Insiders
at The Street - Thu Feb 19, 10:15AM CST
Stocks with insider trader activity include ABMD, CCMP and SGMO
ABMD: 60.15 (-2.04), SGMO: 17.08 (-0.32), CCMP: 51.57 (-0.57)

Exactech (EXAC) Q4 Earnings Top, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 19, 8:56AM CST
Producer of bone and joint restoration products, Exactech Inc. (EXAC), announced adjusted earnings per share (EPS) of 36 cents in the fourth quarter of 2014, which beat the Zacks Consensus Estimate by a couple of cents.
ABMD: 60.15 (-2.04), INGN: 33.34 (-0.28), EXAC: 22.82 (-0.39), LMNX: 15.64 (-0.45)

Patterson Companies (PDCO) Lags Q3 Earnings, Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 19, 8:38AM CST
Patterson Companies Inc. (PDCO) reported third-quarter fiscal 2015 adjusted earnings of 55 cents per share, which missed the Zacks Consensus Estimate of 59 cents and also declined 3.5% from the year-ago quarter.
ABMD: 60.15 (-2.04), INGN: 33.34 (-0.28), PDCO: 50.27 (-0.11), LMNX: 15.64 (-0.45)

Edwards Lifesciences (EW) Shines on Solid Q4, THV Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 19, 7:31AM CST
Edwards Lifesciences (EW) reported adjusted earnings per share of $1.06 in the quarter, exceeding the Zacks Consensus Estimate by a solid 12.8%.
ABMD: 60.15 (-2.04), EW: 134.58 (-1.27), LMNX: 15.64 (-0.45), HOLX: 32.56 (-0.12)

Masimo (MASI) Q4 Earnings, Revenues Top Estimates; Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 18, 9:06AM CST
Masimo Corp (MASI) reported adjusted earnings per share (EPS) of 40 cents in the fourth quarter of 2014 (ending Jan 3, 2015), handily beating the Zacks Consensus estimate of 37 cents.
ABMD: 60.15 (-2.04), MASI: 30.17 (-0.49), INGN: 33.34 (-0.28), LMNX: 15.64 (-0.45)

CryoLife (CRY) Down as Q4 Earnings Fall; Revenues Rise Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 18, 9:03AM CST
CryoLife Inc. (CRY) reported adjusted earnings per share (EPS) of 4 cents in the fourth quarter of 2014, lower than the year-ago equivalent of 7 cents.
ABMD: 60.15 (-2.04), BCR: 167.18 (-1.12), LMNX: 15.64 (-0.45), CRY: 10.55 (+0.04)

Abiomed Hits 52-Week High on Solid Q3, Impella RP Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 17, 9:26AM CST
The bullish run reflects Abiomed Inc.'s (ABMD) strong third-quarter fiscal 2015 results, a raised fiscal 2015 guidance and the recent FDA HDE approval for its Impella RP System.
ABMD: 60.15 (-2.04), FLDM: 41.78 (-2.39), EW: 134.58 (-1.27), LMNX: 15.64 (-0.45)

Lumenis Ltd. (LMNS) in Focus: Stock Jumps 5.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 17, 8:21AM CST
Lumenis Ltd. (LMNS) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
ABMD: 60.15 (-2.04), LMNS: 11.38 (-0.41)

Cepheid's TB Test Wins FDA Clearance for Expanded Use - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 16, 1:00PM CST
Cepheid's (CPHD) Xpert MTB/RIF was shipped to over 10% of the company's North American installed base in its debutant quarter of launch.
ABMD: 60.15 (-2.04), INGN: 33.34 (-0.28), CPHD: 56.76 (-0.52), LMNX: 15.64 (-0.45)


Abiomed (ABMD) Stock Research Links

ABMD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 156

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 294

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 356

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 40

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 107

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Rigetti Computing's Impressive Growth and Strategic Moves Ahead

Updated Category News Views 244

Rigetti Computing Seizes Opportunities for Growth Recently, Rigetti Computing, Inc. (Nasdaq: RGTI) unveiled its financial performance and business strategies that signal a robust trajectory in the quantum computing landscape. Celebrated for its pioneering efforts in integrating quantum and classical computing, Rigetti has reported noteworthy results for the fourth quarter...

Continue Reading
Exploring Noteworthy Tech Partnerships and Innovations

Updated Category News Views 281

Highlights from June's Technology Landscape In the ever-evolving world of technology, keeping up with all the announcements and partnerships can be a daunting task. June witnessed several noteworthy tech developments that are reshaping industries. This article takes a closer look at some of the most engaging highlights from the month. Key Announcements Chainlink and...

Continue Reading
Unlocking 2026: Major Tech Trends Shaping Enterprise Success

Updated Category News Views 262

Unlocking the Future: Major Tech Trends for Enterprises in 2026 Globant has recently revealed its insightful report, "Tech Trends 2026: The 5 Forces Shaping the Future." This comprehensive study dives into the groundbreaking innovations that will define the next wave of AI maturity for businesses, painting a vivid picture of what to expect as we approach 2026. Today,...

Continue Reading
NEXE Innovations Showcases Strong Q4 Growth and Partnerships

Updated Category News Views 215

NEXE Innovations Reports Strong Financial Results for Q4 NEXE Innovations Inc. (TSX.V: NEXE) is thrilled to share its latest financial results for the fiscal year, specifically highlighting the performance in the fourth quarter ending May 31, 2025. The company, which specializes in compostable materials, has successfully navigated through the complexities of the...

Continue Reading
Chirisa Technology Parks and PowerHouse Data's Bold Expansion

Updated Category News Views 246

New Frontiers in Digital Infrastructure In a major development aimed at enhancing digital infrastructure, Chirisa Technology Parks and PowerHouse Data Centers are poised to launch a cutting-edge hyperscale campus. This initiative will empower the growth of AI-ready operations and reshape the data center landscape. What’s notable here isn’t just the tech; it’s also...

Continue Reading